Distinct association of VEGF-A polymorphisms with laryngeal and nasopharyngeal cancer

被引:11
作者
Makni, Lamia [1 ]
Stayoussef, Mouna [2 ]
Ghazouani, Ezeddine [3 ]
Mezlini, Amel [4 ]
Almawi, Wassim Y. [5 ]
BesmaYacoubi-Loueslati [1 ]
机构
[1] El Manar Univ, Fac Sci Tunis, Lab Microorganisms & Act Biomol, Tunis 1092, Tunisia
[2] Univ Monastir, Fac Pharm, Res Unit Hematol & Autoimmune Dis, Monastir, Tunisia
[3] Mil Hosp Tunis, Immunol Lab, Tunis, Tunisia
[4] Salah Azeiz Oncol Inst, Tunis, Tunisia
[5] Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain
关键词
Cancer; Haplotypes; Polymorphisms; VEGF-A; Vascular endothelial growth factor;
D O I
10.1016/j.mgene.2016.02.003
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: We evaluated the association of common VEGF-A SNPs as potential risk factors for laryngeal cancer (LC) and nasopharyngeal carcinoma (NPC) in Tunisians. Methods: Study subjects comprised 73 NPC and 48 LC patients, along with 125 cancer-free control subjects. VEGF-A genotyping was done by the allelic discrimination method. Results: Minor allele frequency (MAF) of the 8 tested VEGF-A SNPs was comparable between LC patients and controls. Significantly higher MAF of rs2010963 and rs833070 were seen in NPC patients compared to controls. Increased nasopharyngeal cancer risk was seen with both rs2010963 and rs833070 as heterozygous, and more so as homozygous states, thus establishing a dose-dependent effect. In addition, increased NPC risk was associated with rs833068 only in heterozygous state. Increased frequency of CCGAACTC haplotype was seen in LC cases than controls. This was in sharp contrast to NPC, where highly significant positive association was seen with ATCGGCCC, ATGAGCCC, CCCAGTCC, and CCGAACCC haplotypes, while ATCAACCC, ATGGACCC, CCCAGCCC, CCCAGCCT, and ATGGATCC haplotypes are protective factors for NPC. Conclusion: VEGF-A SNPs are associated with altered risk of NPC, but not with LC, among Tunisian subjects. (C) 2016 The Authors. Published by Elsevier B. V.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 31 条
[11]  
Fujiwaki R, 2000, ANTICANCER RES, V20, P1317
[12]  
Gong L., 2013, PLOS ONE, V13
[13]   Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer [J].
Guan, Xiaoxiang ;
Zhao, Hui ;
Niu, Jiangong ;
Tan, Dongfeng ;
Ajani, Jaffer A. ;
Wei, Qingyi .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
[14]   ETIOLOGY OF NASOPHARYNGEAL CARCINOMA - A REVIEW [J].
HILDESHEIM, A ;
LEVINE, PH .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (02) :466-485
[15]   Angiogenesis and the expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa [J].
Homer, JJ ;
Prentice, MG ;
Cawkwell, L ;
Birchall, M ;
Greenman, J ;
Stafford, ND .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (10) :1110-1114
[16]   Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis [J].
Jin, QR ;
Hemminki, K ;
Enquist, K ;
Lenner, P ;
Grzybowska, E ;
Klaes, R ;
Henriksson, R ;
Chen, BW ;
Pamula, J ;
Pekala, W ;
Zientek, H ;
Rogozinska-Szczepka, J ;
Utracka-Hutka, B ;
Hallmans, G ;
Försti, A .
CLINICAL CANCER RESEARCH, 2005, 11 (10) :3647-3653
[17]   VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer [J].
Koukourakis, MI ;
Papazoglou, D ;
Giatromanolaki, A ;
Bougioukas, G ;
Maltezos, E ;
Siviridis, E .
LUNG CANCER, 2004, 46 (03) :293-298
[18]   Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervix [J].
Lee, IJ ;
Park, KR ;
Lee, KK ;
Song, JS ;
Lee, KG ;
Lee, JY ;
Cha, DS ;
Choi, HI ;
Kim, DH ;
Deung, YK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03) :768-779
[19]  
Lin L., 2013, PLOS ONE, V1
[20]   Vascular Endothelial Growth Factor (VEGF) Gene Polymorphisms and Breast Cancer Risk in a Chinese Population [J].
Luo, Ting ;
Chen, Long ;
He, Ping ;
Hu, Qian-Cheng ;
Zhong, Xiao-Rong ;
Sun, Yu ;
Yang, Yuan-Fu ;
Tian, Ting-Lun ;
Zheng, Hong .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) :2433-2437